Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CORT
PEN
Add up to 3 more stocks
CORT
Corcept Therapeutics Incorporated
-2.72%
$118.71-3.32Delayed quote: Oct 6, 2026, 1:45 PM EDT
Market Cap
$12.83B
52W Range
$28.66 - $126.38
PEN
Penumbra, Inc.
+0.10%
$317.42+0.31Delayed quote: Oct 6, 2026, 1:45 PM EDT
Market Cap
$12.50B
52W Range
$221.26 - $362.41
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 282.65 | 77.99 |
| Forward P/E | N/A | 67.42 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 18.18 | 8.17 |
| P/S Ratio | 15.45 | 8.31 |
| P/FCF Ratio | 120.02 | 57.91 |
| EV/EBITDA | 1442.60 | 61.18 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 98.3% | 67.8% |
| Operating Margin | 0.8% | 12.4% |
| Net Margin | 6.6% | 10.7% |
| ROE | 7.8% | 10.5% |
| ROA | 6.2% | 8.1% |
| ROIC | 0.9% | 8.5% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.86 | 5.75 |
| Quick Ratio | 2.77 | 3.86 |
| Debt/Equity | 0.01 | 0.14 |
| Interest Coverage | N/A | 144.35 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.